Health
Maker seeking Indian trial of Novavax jab – 7NEWS.com.au
Vaccine maker, the Serum Institute of India, wants to trial the Novavax jab locally, to factor in genetic differences in its population.
The Serum Institute of India, the world’s biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc’s COVID-19 vaccine, which was found to be 89.3 per cent effective in a UK trial.
Serum expected a decision on an Indian trial of Novavax’s vaccine soon, Chief Executive Adar Poonawalla told Reuters on Friday, hours after the US company reported the efficacy data.
“We have already applied to the drug controller’s office for the bridging trial, a few days…
-
General16 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Noosa News23 hours agoSuncorp Stadium upgrades to rival Sydney as seat capacity and infrastructure prioritised
-
Noosa News22 hours agoIn Trent Dalton’s new book Gravity Let Me Go, the bestselling author interrogates himself
-
Noosa News22 hours agoAustralia’s most disaster-prone state urged to prepare ahead of storm, flood and fire season